Follow
Stephen A. Jannetti, Ph.D.
Stephen A. Jannetti, Ph.D.
Postdoctoral Associate, Duke University Medical Center
Verified email at duke.edu
Title
Cited by
Cited by
Year
Targeted brain tumor radiotherapy using an Auger emitter
G Pirovano, SA Jannetti, LM Carter, A Sadique, S Kossatz, N Guru, ...
Clinical Cancer Research 26 (12), 2871-2881, 2020
852020
Poly (ADP-ribose) polymerase (PARP) inhibitors and radiation therapy
SA Jannetti, BM Zeglis, MR Zalutsky, T Reiner
Frontiers in Pharmacology 11, 170, 2020
702020
PARP-1–targeted radiotherapy in mouse models of glioblastoma
SA Jannetti, G Carlucci, B Carney, S Kossatz, L Shenker, LM Carter, ...
Journal of Nuclear Medicine 59 (8), 1225-1233, 2018
582018
From mollusks to medicine: A venomics approach for the discovery and characterization of therapeutics from Terebridae peptide toxins
A Verdes, P Anand, J Gorson, S Jannetti, P Kelly, A Leffler, D Simpson, ...
Toxins 8 (4), 117, 2016
482016
The role of proton transfer in surface-induced dissociation
Z Gregg, W Ijaz, S Jannetti, GL Barnes
The Journal of Physical Chemistry C 118 (38), 22149-22155, 2014
252014
Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers
Y Feng, R Meshaw, D McDougald, Z Zhou, XG Zhao, SA Jannetti, ...
Scientific Reports 12 (1), 3020, 2022
202022
Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models
PL Donabedian, S Kossatz, JA Engelbach, SA Jannetti, B Carney, ...
EJNMMI research 8, 1-10, 2018
172018
Improved radiosynthesis of 123I-MAPi, an auger theranostic agent
TC Wilson, SA Jannetti, N Guru, N Pillarsetty, T Reiner, G Pirovano
International journal of radiation biology 99 (1), 70-76, 2023
152023
Effective treatment of human breast carcinoma xenografts with single-dose 211At-labeled anti-HER2 single-domain antibody fragment
Y Feng, R Meshaw, XG Zhao, S Jannetti, G Vaidyanathan, MR Zalutsky
Journal of Nuclear Medicine 64 (1), 124-130, 2023
142023
Therapeutic efficacy of single-dose iso-[211At] SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts
Y Feng, S Jannetti, R Meshaw, G Vaidyanathan, M Zalutsky
Journal of Nuclear Medicine 62 (supplement 1), 1484-1484, 2021
22021
Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain …
D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ...
Neuro-oncology advances 4 (1), vdac135, 2022
12022
Low Level Whole-Brain Radiation Enhances Theranostic Potential Of Single Domain Antibody Fragments For HER2-Positive Brain Metastases
D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ...
bioRxiv, 2022.04. 19.488555, 2022
2022
Neuro-Oncology Advances
D Procissi, SA Jannetti, M Zannikou, Z Zhou, D McDougald, D Kanojia, ...
2022
PARP1-Targeted Radiotherapies
S Jannetti
The Graduate Center of the City University of New York, 2020
2020
Low-temperature copper-catalyzed formal Bergman cycloaromatizations of bis (2-arylethynyl) benzenes
TS Hughes, ES Thamban, SA Jannetti, JA Olson, MR Scudder
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 242, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–15